Gilead Sciences, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC GILD

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

13,000,814

Value ($000)

1,595,720

Weight

0.3%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	1,595,720	0.3%	13,000,814	12/31/2025
2025 Q3	11/14/2025	1,441,725	0.3%	12,988,515	9/30/2025
2025 Q2	8/14/2025	1,838,566	0.4%	16,583,078	6/30/2025
2025 Q1	5/19/2025	1,541,302	0.4%	13,755,481	3/31/2025
2024 Q4	2/14/2025	1,130,117	0.3%	12,234,672	12/31/2024
2024 Q3	11/14/2024	891,130	0.2%	10,628,942	9/30/2024
2024 Q2	8/14/2024	764,300	0.2%	11,139,775	6/30/2024
2024 Q1	5/15/2024	697,695	0.2%	9,524,841	3/31/2024
2023 Q4	2/14/2024	765,222	0.3%	9,446,025	12/31/2023
2023 Q3	11/13/2023	701,128	0.3%	9,355,861	9/30/2023
2023 Q2	8/11/2023	738,844	0.4%	8,904,953	6/30/2023
2023 Q1	5/15/2023	738,844	0.4%	8,904,953	3/31/2023
2022 Q4	2/14/2023	804,705	0.4%	9,373,385	12/31/2022
2022 Q3	11/14/2022	608,358	0.3%	9,861,529	9/30/2022
2022 Q2	8/12/2022	569,602	0.3%	9,215,363	6/30/2022
2022 Q1	5/16/2022	700,853	0.3%	11,788,943	3/31/2022
2021 Q4	2/14/2022	672,455	0.3%	9,261,190	12/31/2021
2021 Q3	11/15/2021	623,546	0.3%	8,926,935	9/30/2021
2021 Q2	8/16/2021	597,881	0.3%	8,682,554	6/30/2021
2021 Q1	5/14/2021	585,580	0.3%	9,060,504	3/31/2021
2020 Q4	3/1/2021	524,168	0.2%	8,997,053	12/31/2020
2020 Q3	11/13/2020	543,699	0.3%	8,604,194	9/30/2020
2020 Q2	8/14/2020	635,154	0.4%	8,255,185	6/30/2020
2020 Q1	5/15/2020	507,174	0.4%	6,784,035	3/31/2020
2019 Q4	2/14/2020	430,487	0.3%	6,624,913	12/31/2019
2014 Q1	5/23/2014	795,521	0.8%	11,226,666	3/31/2014
2013 Q4	1/31/2014	768,769	0.9%	10,229,786	12/31/2013